Purple glove syndrome following intravenous phenytoin administration

Vascular Medicine

Volumn 12, Issue 1, 2007, Pages 29-31

  Chokshi, Reena ^a   Openshaw, John ^a   Mehta, Nehal N ^a   Mohler III, Emile ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adverse reaction; Intravenous; Phenytoin; Purple glove syndrome; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; LORAZEPAM; PHENYTOIN;

AGED; ARTICLE; CASE REPORT; CATHETER REMOVAL; CENTRAL NERVOUS SYSTEM TUMOR; CRANIOTOMY; DRUG BLOOD LEVEL; GRAND MAL SEIZURE; HAND DISEASE; HAND EDEMA; HUMAN; HYPERTHERMIC THERAPY; INJECTION SITE REACTION; INTRAVENOUS CATHETER; LOADING DRUG DOSE; LYMPHOMA; MALE; MUSCLE WEAKNESS; PAIN; PRIORITY JOURNAL; PURPLE GLOVE SYNDROME; SKIN DISCOLORATION; TONIC CLONIC SEIZURE;

AGED; ANTICONVULSANTS; CYANOSIS; EDEMA; EPILEPSY, TONIC-CLONIC; HAND; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PAIN; PHENYTOIN; SYNDROME;

EID: 34147204276     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X07076551     Document Type: Article

References (10)

1. Burneo JG, Anandan JV, Barkley GL. A prospective study of the incidence of the purple glove syndrome. Epilepsia 2001; 42: 1156-59.
2. Bhattacharjee P, Glusac EJ. Early histopathologic changes in purple glove syndrome. J Cutan Pathol 2004; 31: 513-15.
3. MacCara ME. Extravasation: a hazard of intravenous therapy. Drug Intell Clin Pharm 1983; 17: 713-17.
4. Spengler RF, Arrowsmith JB, Kilarski DJ, Buchanan C, von Behren L, Graham DR. Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors. Arch Intern Med 1988; 148: 1329-33.
5. Ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002; 36: 130-47.
6. Snelson C, Dieckman B. Recognizing and managing purple glove syndrome. Crit Care Nurse 2000; 20: 54-61.
7. Hanna DR. Purple glove syndrome: a complication of intravenous phenytoin. J Neurosci Nurs 1992; 24: 340-45.
8. Yoshikawa H, Abe T, Oda Y. Purple glove syndrome caused by oral administration of phenytoin. J Child Neurol 2000; 15: 762.
9. O'Brien TJ, Cascino GD, So EL, Hanna DR. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology 1998; 51: 1034-39.
10. Touchette DR. Rhoney DH. Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Pharmacotherapy 2000; 20: 908-16.